Related Experiment Video

Updated: Mar 24, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

17.2K

Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics

Mikko T Nieminen1, Paula Vesterinen2, Taina Tervahartiala1

  • 1a Department of Oral and Maxillofacial Diseases , University of Helsinki and Helsinki University Hospital , Helsinki , Finland.

Acute Cardiac Care
|March 17, 2016
PubMed

Insights

A new ELISA assay for matrix metalloproteinase-8 (MMP-8) is as accurate as the standard method for detecting MMP-8 in cardiovascular disease (CVD) patients. This cost-effective assay can aid in identifying patients at risk for CVD.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Matrix metalloproteinases (MMPs), particularly MMP-8, are implicated in inflammatory processes and the progression of atherosclerosis.
  • Elevated MMP-8 levels are associated with cardiovascular diseases (CVDs) and their complications, suggesting its potential as a risk marker.
  • Traditional methods for detecting MMP-8, such as immunofluorometric assay (IFMA), are laborious and expensive.

Discussion:

  • This study introduces and validates a novel, in-house enzyme-linked immunosorbent assay (ELISA) for quantifying serum MMP-8 concentrations.
  • The dentoELISA assay was compared against the established IFMA, demonstrating comparable diagnostic sensitivity and specificity.
  • Receiver Operating Characteristic (ROC) statistics revealed highly similar areas under the curve for both assays, indicating equivalent performance.

Key Insights:

  • The novel ELISA assay for MMP-8 is a cost-effective and less laborious alternative to IFMA.
  • Serum MMP-8 concentrations measured by ELISA correlated significantly with those determined by IFMA (r = 0.881, P < 0.001).
  • MMP-8 levels were significantly higher in patients with acute coronary syndrome compared to a reference population without significant coronary artery disease.

Outlook:

  • The MMP-8 ELISA assay offers a promising new avenue for the diagnostics of cardiovascular diseases.
  • This assay could facilitate more accessible and widespread screening for CVD risk.
  • Further research may explore the clinical utility of MMP-8 ELISA in diverse patient cohorts and for monitoring treatment efficacy.
Keywords:
Coronary diseaseELISAIFMAinflammationmatrix metallo proteinases

More Related Videos

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.8K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.8K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
438
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733